223 related articles for article (PubMed ID: 15778404)
1. The peritoneal cavity provides a protective niche for B1 and conventional B lymphocytes during anti-CD20 immunotherapy in mice.
Hamaguchi Y; Uchida J; Cain DW; Venturi GM; Poe JC; Haas KM; Tedder TF
J Immunol; 2005 Apr; 174(7):4389-99. PubMed ID: 15778404
[TBL] [Abstract][Full Text] [Related]
2. Effects of specific anti-B and/or anti-plasma cell immunotherapy on antibody production in baboons: depletion of CD20- and CD22-positive B cells does not result in significantly decreased production of anti-alphaGal antibody.
Alwayn IP; Xu Y; Basker M; Wu C; Buhler L; Lambrigts D; Treter S; Harper D; Kitamura H; Vitetta ES; Abraham S; Awwad M; White-Scharf ME; Sachs DH; Thall A; Cooper DK
Xenotransplantation; 2001 Aug; 8(3):157-71. PubMed ID: 11472623
[TBL] [Abstract][Full Text] [Related]
3. The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptor-dependent mechanisms during anti-CD20 antibody immunotherapy.
Uchida J; Hamaguchi Y; Oliver JA; Ravetch JV; Poe JC; Haas KM; Tedder TF
J Exp Med; 2004 Jun; 199(12):1659-69. PubMed ID: 15210744
[TBL] [Abstract][Full Text] [Related]
4. Antibody isotype-specific engagement of Fcgamma receptors regulates B lymphocyte depletion during CD20 immunotherapy.
Hamaguchi Y; Xiu Y; Komura K; Nimmerjahn F; Tedder TF
J Exp Med; 2006 Mar; 203(3):743-53. PubMed ID: 16520392
[TBL] [Abstract][Full Text] [Related]
5. Maintenance of long-lived plasma cells and serological memory despite mature and memory B cell depletion during CD20 immunotherapy in mice.
DiLillo DJ; Hamaguchi Y; Ueda Y; Yang K; Uchida J; Haas KM; Kelsoe G; Tedder TF
J Immunol; 2008 Jan; 180(1):361-71. PubMed ID: 18097037
[TBL] [Abstract][Full Text] [Related]
6. [Molecular mechanisms of B lymphocyte depletion by CD20 immunotherapy].
Hamaguchi Y
Nihon Rinsho Meneki Gakkai Kaishi; 2009 Feb; 32(1):29-34. PubMed ID: 19252375
[TBL] [Abstract][Full Text] [Related]
7. B lymphocyte depletion by CD20 monoclonal antibody prevents diabetes in nonobese diabetic mice despite isotype-specific differences in Fc gamma R effector functions.
Xiu Y; Wong CP; Bouaziz JD; Hamaguchi Y; Wang Y; Pop SM; Tisch RM; Tedder TF
J Immunol; 2008 Mar; 180(5):2863-75. PubMed ID: 18292508
[TBL] [Abstract][Full Text] [Related]
8. Fcgamma receptor-dependent effector mechanisms regulate CD19 and CD20 antibody immunotherapies for B lymphocyte malignancies and autoimmunity.
Tedder TF; Baras A; Xiu Y
Springer Semin Immunopathol; 2006 Dec; 28(4):351-64. PubMed ID: 17091246
[TBL] [Abstract][Full Text] [Related]
9. Regulatory B cell production of IL-10 inhibits lymphoma depletion during CD20 immunotherapy in mice.
Horikawa M; Minard-Colin V; Matsushita T; Tedder TF
J Clin Invest; 2011 Nov; 121(11):4268-80. PubMed ID: 22019587
[TBL] [Abstract][Full Text] [Related]
10. B cell depletion inhibits spontaneous autoimmune thyroiditis in NOD.H-2h4 mice.
Yu S; Dunn R; Kehry MR; Braley-Mullen H
J Immunol; 2008 Jun; 180(11):7706-13. PubMed ID: 18490774
[TBL] [Abstract][Full Text] [Related]
11. Role of B1 and B2 lymphocytes in placental ischemia-induced hypertension.
Laule CF; Odean EJ; Wing CR; Root KM; Towner KJ; Hamm CM; Gilbert JS; Fleming SD; Regal JF
Am J Physiol Heart Circ Physiol; 2019 Oct; 317(4):H732-H742. PubMed ID: 31397167
[TBL] [Abstract][Full Text] [Related]
12. Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage FcgammaRI, FcgammaRIII, and FcgammaRIV.
Minard-Colin V; Xiu Y; Poe JC; Horikawa M; Magro CM; Hamaguchi Y; Haas KM; Tedder TF
Blood; 2008 Aug; 112(4):1205-13. PubMed ID: 18495955
[TBL] [Abstract][Full Text] [Related]
13. CD19: a promising B cell target for rheumatoid arthritis.
Tedder TF
Nat Rev Rheumatol; 2009 Oct; 5(10):572-7. PubMed ID: 19798033
[TBL] [Abstract][Full Text] [Related]
14. Mouse CD20 expression and function.
Uchida J; Lee Y; Hasegawa M; Liang Y; Bradney A; Oliver JA; Bowen K; Steeber DA; Haas KM; Poe JC; Tedder TF
Int Immunol; 2004 Jan; 16(1):119-29. PubMed ID: 14688067
[TBL] [Abstract][Full Text] [Related]
15. Low-Dose Subcutaneous Anti-CD20 Treatment Depletes Disease Relevant B Cell Subsets and Attenuates Neuroinflammation.
Huck C; Leppert D; Wegert V; Schmid C; Dunn R; Weckbecker G; Smith PA
J Neuroimmune Pharmacol; 2019 Dec; 14(4):709-719. PubMed ID: 31435856
[TBL] [Abstract][Full Text] [Related]
16. Anti-CD3ε induces splenic B220lo B-cell expansion following anti-CD20 treatment in a mouse model of allosensitization.
Todo T; Wu G; Chai NN; He Y; Martins G; Gupta A; Fair J; Liu NY; Jordan S; Klein A
Int Immunol; 2012 Aug; 24(8):529-38. PubMed ID: 22531063
[TBL] [Abstract][Full Text] [Related]
17. Effect of B-cell depletion using anti-CD20 therapy on inhibitory antibody formation to human FVIII in hemophilia A mice.
Zhang AH; Skupsky J; Scott DW
Blood; 2011 Feb; 117(7):2223-6. PubMed ID: 21160036
[TBL] [Abstract][Full Text] [Related]
18. New anti-CD20 monoclonal antibodies for the treatment of B-cell lymphoid malignancies.
Robak T; Robak E
BioDrugs; 2011 Feb; 25(1):13-25. PubMed ID: 21090841
[TBL] [Abstract][Full Text] [Related]
19. B-cell depletion using an anti-CD20 antibody augments antitumor immune responses and immunotherapy in nonhematopoetic murine tumor models.
Kim S; Fridlender ZG; Dunn R; Kehry MR; Kapoor V; Blouin A; Kaiser LR; Albelda SM
J Immunother; 2008 Jun; 31(5):446-57. PubMed ID: 18463540
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of killing by anti-CD20 monoclonal antibodies.
Glennie MJ; French RR; Cragg MS; Taylor RP
Mol Immunol; 2007 Sep; 44(16):3823-37. PubMed ID: 17768100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
